Stallworth, J.M., AND Jeffords , J.V.: The clinical effects of azapetine on peripheral arterial disease. J. A. M. A., 161: 840, 1956.
2.
Jeffords, J.V. , AND Stallworth, J.M.: The effects of azapetine infusions on patients with vascular disease, preliminary report, Angiology , 7: 445, 1956.
3.
Randall, L.O. , AND Smith, T.H.The adrenergic blocking action of some dibenzazepine derivatives. J. Pharmacol. & Exper. Therap., 103: 10, 1951.
4.
Moore, P.E., Richardson, A.W., AND Green, H.D.: Effects of a new dibenzazepine derivative RC 2-3248, 6-allyl-6, 7-dihydro-5H-dibenz (c,e) azapene phosphate, upon the blood flow; the peripheral resistance, and the response to injections of epinephrine of the innervated hind limb of the dog. J. Pharmacol. & Exper. Therap., 106: 14, 1952.
5.
Johnson, H.D., Green, H.D., AND Lanier, J.T.: Comparison of adrenergic blocking action of Ilidar (RO 2-3248), Regitine (c-7337) and Priscoline in the innervated saphenous arterial bed (skin exclusive of muscle) and femoral arterial bed (muscle exclusive of skin) of the anesthetized dog. J. Pharmacol. & Exper. Therap., 108: 144, 1953 .
6.
Griffin, P.P., Green, H.D., Youmans, P.L., AND Johnson, H.D.Effects of acute and chronic denervation of the hind leg of the dog on the blood flow responses in the vascular beds of skin and muscle of adrenergic drugs, and to adrenergic blockade. J. Pharmacol. & Exper. Therap., 110: 93, 1954.
7.
Green, H.D., AND Dubose, H.H.: Clinical trial of Ilidar, a new dibenzazepine adrenergic blocking drug in the treatment of peripheral vascular diseases and miscellaneous complaints . Circulation, 10: 374, 1954.
8.
Halligan, E.J. , Gibbs, J.C., FR., Grieco, R.V., AND Mckeown, J.E.: An evaluation of peripheral arteriosclerotic insufficiency utilizing radioactive iodinated human serum albumin. Surg., Gynec. & Obst., 102: 511, 1956.